Products

OncoSpot™ NGS Spike-in Reference Standards

Genecopoeia provides OncoSpot™ NGS Spike-in Reference Standards for monitoring the whole process of the detection. The CRISPR method is employed to modify the genome of tumour cells, introducing single nucleotide mutations or in-frame indel mutations. Concurrently, spike-in markers are set up using our patented technology ‘DNA reference standard and use thereof’.

AccelerRT® 5G Full Length cDNA Synthesis & Amplification Kit

[tab:Product Information] The AccelerRT® 5G Full Length cDNA Synthesis & Amplification Kit can synthesize cDNA ranging from 1-1000 cells or 10 pg - 100 ng of total RNA and an Oligo(dT)VN Primer as a reverse...

DNase I

[tab:Product Information] DNase I is an endonuclease that digests single- and double- stranded DNA. It hydrolyzes phosphodiester bonds producing mono- and oligodeoxyribonucleotides with 5’-phosphate...

T4 DNA Ligase

[tab:Product Information] T4 DNA Ligase catalyzes the formation of a phosphodiester bond between juxtaposed 5’-phosphate and 3’-hydroxyl termini in duplex DNA or RNA. The enzyme repairs single-strand...

OmicsLink™ Antibody Products

GeneCopoeia provides a diverse variety of antibodies suitable for research areas including cancer, epigenetics, immunology and neuroscience. GeneCopoeia’s...

Antibody & Protein

OmicsLink™ Antibody Products GeneCopoeia’s high-quality antibodies undergo a strict performance verification process and provide excellent results across multiple applications such as WB,...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.